Insulin Glargine (Lantus) Biosimilars — Save Thousands
FDA-approved biosimilars for Insulin Glargine (Lantus) offer the same efficacy and safety at up to 40% lower cost — saving up to $140/year. Script Unlock connects you with pharmacies offering biosimilar pricing.
Reference product
$350
Insulin Glargine (Lantus)
Biosimilar price
from $210
save up to 40%
FDA-Approved Insulin Glargine (Lantus) Biosimilars
SemgleeRezvoglarBasaglar
Are Biosimilars as Effective as Insulin Glargine (Lantus)?
- FDA requires biosimilars to have no clinically meaningful differences in safety or efficacy
- Same active ingredient, same mechanism of action
- Interchangeable biosimilars can be substituted without prescriber intervention
- Extensive clinical studies required before FDA approval